HIF1A and neoplasm: HIF-1α impedes immune surveillance and natural killer (NK) cell infiltration by interfering with MHC class I polypeptide-related sequence A (MICA) and inhibiting the expression of natural cytotoxic receptors and the activator NKG2D, thereby interrupting tumor antigen recognition [15,16].